Cargando…

Longitudinal Alterations in Gait Features in Growing Children With Duchenne Muscular Dystrophy

Prolonging ambulation is an important treatment goal in children with Duchenne muscular dystrophy (DMD). Three-dimensional gait analysis (3DGA) could provide sensitive parameters to study the efficacy of clinical trials aiming to preserve ambulation. However, quantitative descriptions of the natural...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vandekerckhove, Ines, Van den Hauwe, Marleen, De Beukelaer, Nathalie, Stoop, Elze, Goudriaan, Marije, Delporte, Margaux, Molenberghs, Geert, Van Campenhout, Anja, De Waele, Liesbeth, Goemans, Nathalie, De Groote, Friedl, Desloovere, Kaat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201072/ https://www.ncbi.nlm.nih.gov/pubmed/35721358 http://dx.doi.org/10.3389/fnhum.2022.861136

Ejemplares similares

Muscle weakness has a limited effect on motor control of gait in Duchenne muscular dystrophy
por: Vandekerckhove, Ines, et al.
Publicado: (2020)

Instrumented strength assessment in typically developing children and children with a neural or neuromuscular disorder: A reliability, validity and responsiveness study
por: Verreydt, Ineke, et al.
Publicado: (2022)

Non-neural Muscle Weakness Has Limited Influence on Complexity of Motor Control during Gait
por: Goudriaan, Marije, et al.
Publicado: (2018)

Morphological Medial Gastrocnemius Muscle Growth in Ambulant Children with Spastic Cerebral Palsy: A Prospective Longitudinal Study
por: De Beukelaer, Nathalie, et al.
Publicado: (2023)

Individualized Prediction of Changes in 6-Minute Walk Distance for Patients with Duchenne Muscular Dystrophy
por: Goemans, Nathalie, et al.
Publicado: (2016)

Human iPSC model reveals a central role for NOX4 and oxidative stress in Duchenne cardiomyopathy
por: Duelen, Robin, et al.
Publicado: (2022)

A new strength assessment to evaluate the association between muscle weakness and gait pathology in children with cerebral palsy
por: Goudriaan, Marije, et al.
Publicado: (2018)

Movement History Influences Pendulum Test Kinematics in Children With Spastic Cerebral Palsy
por: Willaert, Jente, et al.
Publicado: (2020)

Reduced reciprocal inhibition during clinical tests of spasticity is associated with impaired reactive standing balance control in children with cerebral palsy
por: Willaert, Jente, et al.
Publicado: (2023)

Structural Brain Lesions and Gait Pathology in Children With Spastic Cerebral Palsy
por: Papageorgiou, Eirini, et al.
Publicado: (2020)

Muscle Characteristics in Pediatric Hereditary Spastic Paraplegia vs. Bilateral Spastic Cerebral Palsy: An Exploratory Study
por: De Beukelaer, Nathalie, et al.
Publicado: (2021)

The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy
por: Hanssen, Britta, et al.
Publicado: (2021)

Long-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study
por: Goemans, Nathalie M., et al.
Publicado: (2016)

Progressive resistance training for children with cerebral palsy: A randomized controlled trial evaluating the effects on muscle strength and morphology
por: Hanssen, Britta, et al.
Publicado: (2022)

Reduced Cross-Sectional Muscle Growth Six Months after Botulinum Toxin Type-A Injection in Children with Spastic Cerebral Palsy
por: De Beukelaer, Nathalie, et al.
Publicado: (2022)

Prognostic factors for changes in the timed 4-stair climb in patients with Duchenne muscular dystrophy, and implications for measuring drug efficacy: A multi-institutional collaboration
por: Goemans, Nathalie, et al.
Publicado: (2020)

Botulinum Toxin Treatment of Adult Muscle Stem Cells from Children with Cerebral Palsy and hiPSC-Derived Neuromuscular Junctions
por: Costamagna, Domiziana, et al.
Publicado: (2023)

The Short-Term Impact of Botulinum Neurotoxin-A on Muscle Morphology and Gait in Children with Spastic Cerebral Palsy
por: Peeters, Nicky, et al.
Publicado: (2022)

Muscle synergy structure and gait patterns in children with spastic cerebral palsy
por: Goudriaan, Marije, et al.
Publicado: (2021)

Muscle Microbiopsy to Delineate Stem Cell Involvement in Young Patients: A Novel Approach for Children With Cerebral Palsy
por: Corvelyn, Marlies, et al.
Publicado: (2020)

Fine-needle percutaneous muscle microbiopsy technique as a feasible tool to address histological analysis in young children with cerebral palsy and age-matched typically developing children
por: Deschrevel, Jorieke, et al.
Publicado: (2023)

A spasticity model based on feedback from muscle force explains muscle activity during passive stretches and gait in children with cerebral palsy
por: Falisse, Antoine, et al.
Publicado: (2018)

Lessons Learned from Discontinued Clinical Developments in Duchenne Muscular Dystrophy
por: Markati, Theodora, et al.
Publicado: (2021)

Pre-treatment EMG can be used to model post-treatment muscle coordination during walking in children with cerebral palsy
por: Pitto, Lorenzo, et al.
Publicado: (2020)

Muscle synergies demonstrate only minimal changes after treatment in cerebral palsy
por: Shuman, Benjamin R., et al.
Publicado: (2019)

Muscle Synergy Constraints Do Not Improve Estimates of Muscle Activity From Static Optimization During Gait for Unimpaired Children or Children With Cerebral Palsy
por: Shuman, Benjamin R., et al.
Publicado: (2019)

SimCP: A Simulation Platform to Predict Gait Performance Following Orthopedic Intervention in Children With Cerebral Palsy
por: Pitto, Lorenzo, et al.
Publicado: (2019)

Six-Minute Walk Test: Reference Values and Prediction Equation in Healthy Boys Aged 5 to12 Years
por: Goemans, Nathalie, et al.
Publicado: (2013)

Physics-Based Simulations to Predict the Differential Effects of Motor Control and Musculoskeletal Deficits on Gait Dysfunction in Cerebral Palsy: A Retrospective Case Study
por: Falisse, Antoine, et al.
Publicado: (2020)

Treatment Response to Botulinum Neurotoxin-A in Children With Cerebral Palsy Categorized by the Type of Stretch Reflex Muscle Activation
por: Bar-On, Lynn, et al.
Publicado: (2020)

Suitability of external controls for drug evaluation in Duchenne muscular dystrophy
por: Goemans, Nathalie, et al.
Publicado: (2020)

Children with Spastic Cerebral Palsy Experience Difficulties Adjusting Their Gait Pattern to Weight Added to the Waist, While Typically Developing Children Do Not
por: Meyns, Pieter, et al.
Publicado: (2016)

Are spasticity, weakness, selectivity, and passive range of motion related to gait deviations in children with spastic cerebral palsy? A statistical parametric mapping study
por: Papageorgiou, Eirini, et al.
Publicado: (2019)

Spasticity and Its Contribution to Hypertonia in Cerebral Palsy
por: Bar-On, Lynn, et al.
Publicado: (2015)

International workshop on assessment of upper limb function in Duchenne Muscular Dystrophy: Rome, 15–16 February 2012
por: Mercuri, Eugenio, et al.
Publicado: (2012)

The Myotube Analyzer: how to assess myogenic features in muscle stem cells
por: Noë, Simon, et al.
Publicado: (2022)

Treatment effect of idebenone on inspiratory function in patients with Duchenne muscular dystrophy
por: Buyse, Gunnar M., et al.
Publicado: (2016)

Comparison of Long-term Ambulatory Function in Patients with Duchenne Muscular Dystrophy Treated with Eteplirsen and Matched Natural History Controls
por: Mendell, Jerry R., et al.
Publicado: (2021)

Autologous iPSC-Derived Human Neuromuscular Junction to Model the Pathophysiology of Hereditary Spastic Paraplegia
por: Costamagna, Domiziana, et al.
Publicado: (2022)

The Dilemma of Choice for Duchenne Patients Eligible for Exon 51 Skipping The European Experience
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q6v6r0396boob3lda7bf9mssjs